In Brief: Rhone-Poulenc Rorer
This article was originally published in The Tan Sheet
Executive Summary
Rhone-Poulenc Rorer: Acquires from Rhone-Poulenc two overseas drug businesses -- Cooperation Pharmaceutique Francaise (Cooper) and Brazil-based Rhodia -- for $260 mil. in cash and preferred shares issued by RPR's French subsidiary RPR SA, the firm reported May 22. RPR is characterizing the deal as further consolidation of the Rhone-Poulenc pharmaceutical businesses under RPR, which is 68% owned by Rhone-Poulenc. Rhone-Poulenc SA acquired Cooper in April 1994 ("The Tan Sheet" Feb. 28, 1994, p. 1)). The French firm had $450 mil. in drug and surgical supply sales in 1994. Rhone-Poulenc Labo Managing Director Yves Baja will have responsibility for Cooper..